Prothena | PRTA - Trade Creditors


Prothena reported $10.5M in Trade Creditors for its fiscal quarter ending in September of 2025.





Trade Creditors Change Date
Acadia Pharmaceuticals USD 10.9M 10.84M Dec/2025
Agios Pharmaceuticals USD 18.36M 1.2M Dec/2025
Akebia Therapeutics USD 21.18M 11.1M Dec/2025
ALKERMES USD 107.95M 39.95M Dec/2025
Alnylam Pharmaceuticals USD 115.72M 1.87M Dec/2025
Amgen USD 20.89B 1.25B Dec/2025
Biogen USD 432M 18.9M Dec/2025
BioMarin Pharmaceutical USD 759.03M 39.41M Dec/2025
Exelixis USD 29.62M 4.27M Dec/2025
Immunic USD 7.92M 25K Sep/2025
Incyte USD 1.63B 1.46B Dec/2025
Ionis Pharmaceuticals USD 14.33M 8.47M Sep/2025
MacroGenics USD 5.94M 1.28M Sep/2025
Nektar Therapeutics USD 15.56M 1.28M Sep/2025
Neurocrine Biosciences USD 545.5M 425.6M Dec/2025
Prothena USD 10.5M 1.7M Sep/2025
Regeneron Pharmaceuticals USD 5.83B 4.93B Dec/2025
Ultragenyx Pharmaceutical USD 40.57M 6.33M Sep/2025
Vertex Pharmaceuticals USD 3.43B 600.9M Dec/2025
Xoma USD 2.65M 1.52M Sep/2025